SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.000p
   
  • Closing Price Chg:
      1.00p
  • 52 Week High: 26.10
  • 52 Week Low: 12.25
  • Currency: UK Pounds
  • Shares Issued: 258.78m
  • Volume: 0
  • Beta: 0.49

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
98.66% above the market average98.66% above the market average98.66% above the market average98.66% above the market average98.66% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
67.02% above the market average67.02% above the market average67.02% above the market average67.02% above the market average67.02% above the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average
Price Book Ratio
93.76% below the market average93.76% below the market average93.76% below the market average93.76% below the market average93.76% below the market average
65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
79.28% below the market average79.28% below the market average79.28% below the market average79.28% below the market average79.28% below the market average
72.73% below the sector average72.73% below the sector average72.73% below the sector average72.73% below the sector average72.73% below the sector average
Price Chg 3m
80.74% below the market average80.74% below the market average80.74% below the market average80.74% below the market average80.74% below the market average
68.18% below the sector average68.18% below the sector average68.18% below the sector average68.18% below the sector average68.18% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
53.25% below the market average53.25% below the market average53.25% below the market average53.25% below the market average53.25% below the market average
56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average
Momentum 20
39.05% below the market average39.05% below the market average39.05% below the market average39.05% below the market average39.05% below the market average
56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
84.96% below the market average84.96% below the market average84.96% below the market average84.96% below the market average84.96% below the market average
35.71% below the sector average35.71% below the sector average35.71% below the sector average35.71% below the sector average35.71% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
63.36% below the market average63.36% below the market average63.36% below the market average63.36% below the market average63.36% below the market average
47.62% below the sector average47.62% below the sector average47.62% below the sector average47.62% below the sector average47.62% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
79.03% below the market average79.03% below the market average79.03% below the market average79.03% below the market average79.03% below the market average
35.71% below the sector average35.71% below the sector average35.71% below the sector average35.71% below the sector average35.71% below the sector average
Operating Profit Loss
64.42% below the market average64.42% below the market average64.42% below the market average64.42% below the market average64.42% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
74.49% below the market average74.49% below the market average74.49% below the market average74.49% below the market average74.49% below the market average
48.72% below the sector average48.72% below the sector average48.72% below the sector average48.72% below the sector average48.72% below the sector average
Cash
62.58% below the market average62.58% below the market average62.58% below the market average62.58% below the market average62.58% below the market average
46.34% below the sector average46.34% below the sector average46.34% below the sector average46.34% below the sector average46.34% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 20.00p
Closing Price Change 1.00p
% Change 0.00 %
52 Week High 26.10
52 Week Low 12.25
Volume 0
Shares Issued 258.78m
Beta 0.49

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average
75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average
Price Trend
36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Income Not Available
Growth
49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average
72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average

SBTX Dividends

No dividends found

Trades for 09-Jan-2026

Time Volume / Share Price
09:11 36,002 @ 20.10p
09:10 1,960 @ 20.10p
09:08 50,000 @ 20.28p
09:07 10,000 @ 20.28p
09:07 31,719 @ 20.30p

SBTX Key Personnel

CEO Stuart Ashman
CFO Emily Bertram

Top of Page